An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia
Neena Valecha, Aung Pyae Phyo, Mayfong Mayxay et al. · 2010
Read An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia by Neena Valecha, Aung Pyae Phyo, Mayfong Mayxay et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011880.txt.
Description
Neena Valecha and a large team ran in 2010 an open-label randomized trial in Asia comparing two combination treatments for falciparum malaria. One pairing joined dihydroartemisinin with piperaquine; the other joined artesunate with mefloquine, a standard option. The newer pairing had shown promise against malaria parasites that resist several older drugs.
Patients were assigned to one treatment or the other, and the goal was to show the newer pairing was not worse than the standard. Head-to-head trials like this decide what clinics across a region should stock first. A treatment that matches the standard while covering resistant parasites would give malaria programs a stronger first line where drug resistance keeps spreading.
Catalog record
| CREATOR | Neena Valecha, Aung Pyae Phyo, Mayfong Mayxay et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 66 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011880